Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1971 1
1974 1
1977 1
1981 1
1982 2
1983 10
1984 3
1985 5
1986 10
1987 13
1988 7
1989 5
1990 7
1991 4
1992 6
1993 4
1994 5
1995 15
1996 12
1997 10
1998 9
1999 6
2000 5
2001 8
2002 7
2003 1
2004 12
2005 7
2006 10
2007 19
2008 25
2009 19
2010 21
2011 19
2012 23
2013 14
2014 12
2015 14
2016 22
2017 23
2018 24
2019 23
2020 13
2021 21
2022 27
2023 33
2024 25
2025 13
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Results by year

Filters applied: . Clear all
Page 1
PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization.
Ito J, Nakamura T, Toyama T, Chen D, Berndt C, Poschmann G, Mourão ASD, Doll S, Suzuki M, Zhang W, Zheng J, Trümbach D, Yamada N, Ono K, Yazaki M, Kawai Y, Arisawa M, Ohsaki Y, Shirakawa H, Wahida A, Proneth B, Saito Y, Nakagawa K, Mishima E, Conrad M. Ito J, et al. Among authors: shirakawa h. Mol Cell. 2024 Dec 5;84(23):4629-4644.e9. doi: 10.1016/j.molcel.2024.10.028. Epub 2024 Nov 14. Mol Cell. 2024. PMID: 39547222 Free article.
Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.
Unno M, Motoi F, Matsuyama Y, Satoi S, Toyama H, Matsumoto I, Aosasa S, Shirakawa H, Wada K, Fujii T, Yoshitomi H, Takahashi S, Sho M, Ueno H, Kosuge T. Unno M, et al. Among authors: shirakawa h. Ann Surg. 2026 Jan 1;283(1):57-64. doi: 10.1097/SLA.0000000000006730. Epub 2025 Apr 16. Ann Surg. 2026. PMID: 40235447 Free PMC article. Clinical Trial.
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.
Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Ohba A, et al. Among authors: shirakawa h. J Clin Oncol. 2025 Nov;43(31):3345-3354. doi: 10.1200/JCO.24.00936. Epub 2025 Jul 28. J Clin Oncol. 2025. PMID: 40720715 Free PMC article. Clinical Trial.
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment.
Hagihara H, Shoji H, Hattori S, Sala G, Takamiya Y, Tanaka M, Ihara M, Shibutani M, Hatada I, Hori K, Hoshino M, Nakao A, Mori Y, Okabe S, Matsushita M, Urbach A, Katayama Y, Matsumoto A, Nakayama KI, Katori S, Sato T, Iwasato T, Nakamura H, Goshima Y, Raveau M, Tatsukawa T, Yamakawa K, Takahashi N, Kasai H, Inazawa J, Nobuhisa I, Kagawa T, Taga T, Darwish M, Nishizono H, Takao K, Sapkota K, Nakazawa K, Takagi T, Fujisawa H, Sugimura Y, Yamanishi K, Rajagopal L, Hannah ND, Meltzer HY, Yamamoto T, Wakatsuki S, Araki T, Tabuchi K, Numakawa T, Kunugi H, Huang FL, Hayata-Takano A, Hashimoto H, Tamada K, Takumi T, Kasahara T, Kato T, Graef IA, Crabtree GR, Asaoka N, Hatakama H, Kaneko S, Kohno T, Hattori M, Hoshiba Y, Miyake R, Obi-Nagata K, Hayashi-Takagi A, Becker LJ, Yalcin I, Hagino Y, Kotajima-Murakami H, Moriya Y, Ikeda K, Kim H, Kaang BK, Otabi H, Yoshida Y, Toyoda A, Komiyama NH, Grant SGN, Ida-Eto M, Narita M, Matsumoto KI, Okuda-Ashitaka E, Ohmori I, Shimada T, Yamagata K, Ageta H, Tsuchida K, Inokuchi K, Sassa T, Kihara A, Fukasawa M, Usuda N, Katano T, Tanaka T, Yoshihara Y, Igarashi M, Hayashi T, Ishikawa K, Yamamoto S, Nishimura N, Nakada K, Hirotsune S, Egawa K, Higashis… See abstract for full author list ➔ Hagihara H, et al. Among authors: shirakawa h. Elife. 2024 Mar 26;12:RP89376. doi: 10.7554/eLife.89376. Elife. 2024. PMID: 38529532 Free PMC article.
TRP Channels in the Brain: What Are They There For?
Sawamura S, Shirakawa H, Nakagawa T, Mori Y, Kaneko S. Sawamura S, et al. Among authors: shirakawa h. In: Emir TLR, editor. Neurobiology of TRP Channels. Boca Raton (FL): CRC Press/Taylor & Francis; 2017. Chapter 16. In: Emir TLR, editor. Neurobiology of TRP Channels. Boca Raton (FL): CRC Press/Taylor & Francis; 2017. Chapter 16. PMID: 29356477 Free Books & Documents. Review.
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer.
Sakamoto Y, Morizane C, Okusaka T, Mizusawa J, Hiraoka N, Shirota T, Ueno M, Kobayashi S, Ikeda M, Imaoka H, Ozaka M, Okano N, Yamaguchi H, Mizuno N, Nishina T, Katanuma A, Kojima Y, Gotoh K, Okamura K, Kawamoto Y, Sugimori K, Terashima T, Sugimoto R, Shirakawa H, Furuse J. Sakamoto Y, et al. Among authors: shirakawa h. Sci Rep. 2025 Sep 30;15(1):33862. doi: 10.1038/s41598-025-07058-7. Sci Rep. 2025. PMID: 41028776 Free PMC article. Clinical Trial.
543 results